20 articles
Bacteriophages transferred during FMT may drive horizontal gene transfer, altering microbial function and antibiotic resistance in ways science has largely ignored.
A completed trial explores whether a low-fibre diet can ease intestinal dysmotility — one of the most debilitating but overlooked symptoms of mitochondrial disease.
Bacterial metabolite from flavonoids protects against graft-versus-host disease while preserving anti-cancer effects in stem cell transplants.
Clinical trial tests whether fecal transplants from young, active donors can restore muscle strength and cognitive function in older adults.
Scientists examine how measurement methods and biological pathways influence inherited fatty liver disease risk patterns.
New research reveals how microbes transform organic matter, offering insights for optimizing digestive health and energy metabolism.
New research explores whether transplanting gut bacteria from vegans can reduce TMAO, a compound linked to heart disease, cancer, and diabetes.
Comprehensive review reveals how gut bacteria modify human gene expression through epigenetic mechanisms, opening new therapeutic avenues.
Vaginal microbiota applied to C-section newborns restores a key brain-signaling molecule on skin, improving early neurodevelopment.
A double-blind RCT finds FMT capsules added to escitalopram reduce depression scores faster via bile acid and anti-inflammatory pathways.
New research reveals how gut microbes produce fatty acids that hijack cellular cleanup systems, leading to fat accumulation and immune dysfunction.
New perspective reveals why gut microbiome discoveries struggle to translate into effective clinical treatments
Multi-omics study reveals how specific gut microbes produce acetate to protect liver function and prevent metabolic disorders in dairy cows.
New research reveals how beneficial microbes adapt their behavior to different hosts, offering insights for personalized microbiome therapies.
Go beyond probiotics and fiber — explore the cutting-edge science of fecal microbiota transplantation, engineered postbiotics, and how the gut orchestrates systemic aging through immune and neural circuits.
A landmark review reveals how microbiome disruption before and after stem cell transplants drives deadly graft-versus-host disease.
Researchers discover unique RNA structures in bacteria that could inspire new approaches to cellular optimization and aging.
Fecal transplants from cancer survivors significantly improved treatment outcomes for metastatic kidney cancer patients.
Synthetic biology meets the microbiome: designer probiotics restore gut-liver-brain balance better than rifaximin in preclinical models.
Fecal microbiota transplants dramatically improved immune checkpoint inhibitor response rates in lung cancer and melanoma patients.
